2393 — Yestar Healthcare Holdings Co Balance Sheet
0.000.00%
- HK$289.12m
- HK$381.80m
- CNY2.41bn
- 50
- 82
- 83
- 87
Annual balance sheet for Yestar Healthcare Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 625 | 637 | 351 | 226 | 116 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,480 | 1,605 | 1,451 | 620 | 547 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,824 | 2,824 | 2,498 | 2,867 | 1,086 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 429 | 460 | 432 | 258 | 121 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 4,655 | 4,559 | 3,370 | 3,426 | 1,430 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,288 | 2,161 | 3,500 | 3,721 | 805 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3,898 | 3,804 | 3,779 | 3,884 | 968 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 757 | 755 | -409 | -458 | 462 |
| Total Liabilities & Shareholders' Equity | 4,655 | 4,559 | 3,370 | 3,426 | 1,430 |
| Total Common Shares Outstanding |